Your browser doesn't support javascript.
loading
The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.
Bedford, Peter; Hauke, Daniel J; Wang, Zheng; Roth, Volker; Nagy-Huber, Monika; Holze, Friederike; Ley, Laura; Vizeli, Patrick; Liechti, Matthias E; Borgwardt, Stefan; Müller, Felix; Diaconescu, Andreea O.
Afiliação
  • Bedford P; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
  • Hauke DJ; Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK. d.hauke@ucl.ac.uk.
  • Wang Z; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
  • Roth V; Department of Mathematics and Computer Science, University of Basel, Basel, Switzerland.
  • Nagy-Huber M; Department of Mathematics and Computer Science, University of Basel, Basel, Switzerland.
  • Holze F; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Ley L; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Vizeli P; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Liechti ME; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Borgwardt S; Department of Psychiatry and Psychotherapy, Translational Psychiatry, Lübeck, Germany.
  • Müller F; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Diaconescu AO; Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Neuropsychopharmacology ; 48(8): 1175-1183, 2023 07.
Article em En | MEDLINE | ID: mdl-37185950
ABSTRACT
Psychedelics have emerged as promising candidate treatments for various psychiatric conditions, and given their clinical potential, there is a need to identify biomarkers that underlie their effects. Here, we investigate the neural mechanisms of lysergic acid diethylamide (LSD) using regression dynamic causal modelling (rDCM), a novel technique that assesses whole-brain effective connectivity (EC) during resting-state functional magnetic resonance imaging (fMRI). We modelled data from two randomised, placebo-controlled, double-blind, cross-over trials, in which 45 participants were administered 100 µg LSD and placebo in two resting-state fMRI sessions. We compared EC against whole-brain functional connectivity (FC) using classical statistics and machine learning methods. Multivariate analyses of EC parameters revealed predominantly stronger interregional connectivity and reduced self-inhibition under LSD compared to placebo, with the notable exception of weakened interregional connectivity and increased self-inhibition in occipital brain regions as well as subcortical regions. Together, these findings suggests that LSD perturbs the Excitation/Inhibition balance of the brain. Notably, whole-brain EC did not only provide additional mechanistic insight into the effects of LSD on the Excitation/Inhibition balance of the brain, but EC also correlated with global subjective effects of LSD and discriminated experimental conditions in a machine learning-based analysis with high accuracy (91.11%), highlighting the potential of using whole-brain EC to decode or predict subjective effects of LSD in the future.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Dietilamida do Ácido Lisérgico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Dietilamida do Ácido Lisérgico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article